Phospholipase A2 expression in tumours: a target for therapeutic intervention?
- 12 August 2003
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 8 (15), 710-716
- https://doi.org/10.1016/s1359-6446(03)02754-5
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- COX-2, Inflammatory Secreted PLA2, and Cytoplasmic PLA2 Protein Expression in Small Bowel Adenocarcinomas Compared with Colorectal AdenocarcinomasLaboratory Investigation, 2003
- Biological effects of group IIA secreted phosholipase A2FEBS Letters, 2002
- Identification of the Modifier of Min 2 (Mom2) Locus, a New Mutation That Influences Apc-Induced Intestinal NeoplasiaGenome Research, 2002
- Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectumEuropean Journal of Surgical Oncology, 2001
- REGULATION AND INHIBITION OF PHOSPHOLIPASE A2Annual Review of Pharmacology and Toxicology, 1999
- Secretory Type II Phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosaOncogene, 1998
- Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomasCancer Letters, 1997
- Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumoursAnnals of Human Genetics, 1996
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993
- A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAPCell, 1991